- Home
- PKE vs VNDA Comparison
PKE vs VNDA Comparison
Compare PKE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- VNDA
- Stock Information
- Founded
- PKE 1954
- VNDA 2002
- Country
- PKE United States
- VNDA United States
- Employees
- PKE N/A
- VNDA N/A
- Industry
- PKE Military/Government/Technical
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- PKE Industrials
- VNDA Health Care
- Exchange
- PKE Nasdaq
- VNDA Nasdaq
- Market Cap
- PKE 378.7M
- VNDA 249.4M
- IPO Year
- PKE N/A
- VNDA 2006
- Fundamental
- Price
- PKE $19.19
- VNDA $4.38
- Analyst Decision
- PKE
- VNDA Strong Buy
- Analyst Count
- PKE 0
- VNDA 2
- Target Price
- PKE N/A
- VNDA $16.50
- AVG Volume (30 Days)
- PKE 94.6K
- VNDA 388.7K
- Earning Date
- PKE 10-14-2025
- VNDA 11-05-2025
- Dividend Yield
- PKE 2.61%
- VNDA N/A
- EPS Growth
- PKE 4.18
- VNDA N/A
- EPS
- PKE 0.34
- VNDA N/A
- Revenue
- PKE $63,456,000.00
- VNDA $203,467,000.00
- Revenue This Year
- PKE N/A
- VNDA $15.45
- Revenue Next Year
- PKE N/A
- VNDA $37.82
- P/E Ratio
- PKE $55.06
- VNDA N/A
- Revenue Growth
- PKE 16.60
- VNDA 11.78
- 52 Week Low
- PKE $11.97
- VNDA $3.81
- 52 Week High
- PKE $20.73
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- PKE 58.75
- VNDA 41.13
- Support Level
- PKE $18.20
- VNDA $4.54
- Resistance Level
- PKE $19.29
- VNDA $4.64
- Average True Range (ATR)
- PKE 0.65
- VNDA 0.15
- MACD
- PKE -0.06
- VNDA -0.02
- Stochastic Oscillator
- PKE 70.21
- VNDA 0.00
About PKE Park Aerospace Corp.
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.